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Background
In the absence of evidence-based guidelines, we investi-
gate current European practices for the clinical manage-
ment and treatment of children coinfected with HIV and
Hepatitis C virus (HCV).
Material and methods
A semi-structured questionnaire survey in clinical centres
from 7 European countries who were either enrolling in
the European Collaborative Study of HIV-infected preg-
nant women and their children or the European Paediat-
ric HCV Network of children born to HCV-infected
mothers.
Results
To date we have received responses from clinicians from
16 centres, caring for a total of 35 HIV/HCV coinfected
children. Four centres were not currently following any
coinfected children. Only one centre had a written policy
for the management and treatment of HIV/HCV coin-
fected children and in most other centres (8/11, 72%)
decisions regarding the care of coinfected children were
taken at the hospital or departmental level with only 3 out
of 11 centres relying on regional or national decision-
making. In addition to standard laboratory tests for mon-
itoring HIV disease (HIV RNA quantification, CD4 counts
etc), 6/12 centres also performed HCV RNA PCR tests at
least annually and 6/12 centres carried out ALT and AST
tests at least every 6 months in coinfected children. Liver
biopsy was rarely performed but liver ultrasound was per-
formed in 5 out of 12 centres at least annually. 91% of 11
centres performed HCV genotyping on all HIV/HCV coin-
fected children and 88% of 8 centres monitored for evi-
dence of hepatotoxicity in coinfected children receiving
antiretroviral treatment for HIV disease. Only one centre
had ever treated coinfected children for HIV and HCV
infections concurrently but 4/7 other centres stated they
would consider treatment at the same time if necessary. In
the situation of an HIV/HCV coinfection diagnosis later in
childhood, 3/7 respondents stated that they would treat
HCV infection before starting HIV therapy.
Conclusions
In the absence of guidelines for the clinical management
of children coinfected with HIV and HCV, practices
throughout Europe vary widely. Individual centres see rel-
atively few coinfected children and therefore a lack of
experience in the management of this group and the lack
of evidence-based policy may be a barrier to achieving
optimal care and treatment. This survey highlights the
importance of research focused on this group of children
to inform guidelines for their best possible care.
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